- Cost: $799
Molecular Biomarkers-2016 aims to put forth a global platform in Berlin, Germany during September 15-17, 2016, to share experience, knowledge, enlighten young aspiring minds on the latest advancements in the field of molecular and cancer biomarkers and to deliver novel ideas besides incorporating better understanding of the disease diagnosis, prognosis and therapeutic intervention. The conference expects the participation of experts from various cross disciplines like pathology, oncology, genomics, proteomics, doctors, pharmacologists, clinicians and technology development in the related fields.
Molecular biomarkers will, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of diseases with obvious applications in analytic epidemiology, clinical trials and disease prevention, diagnosis, and disease management. Molecular biomarkers have the additional potential to identify individuals susceptible to disease. Classification of populations in terms of the degree of susceptibility on the basis of such biomarkers produces greater accuracy than relying on historical definitions of susceptibility.
In the recent years, knowledge about cancer biomarkers has increased tremendously providing great opportunities for improving the management of cancer patients by enhancing the efficiency of detection and efficacy of treatment. Recent technological advancement has enabled the examination of many potential biomarkers and renewed interest in developing new biomarkers. A comprehensive understanding of the relevance of each biomarker will be very important not only for diagnosing the disease reliably, but also help in the choice of multiple therapeutic alternatives currently available that is likely to benefit the patients.